Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (111-120 of 349) with videos related to

Pageof 35
Sort By:
Clinical and Translational Science|October 20, 2021
Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non-JapaneseEunsol Yang, Jung Sunwoo, Ki Young Huh, et al.
Clinical Pharmacology in Drug Development|June 23, 2021
Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan and Chlorthalidone Compared to Concurrent Administration of the Separate ComponentsInseung Jeon, Seol Ju Moon, Sang-In Park, et al.
Translational and Clinical Pharmacology|January 11, 2021
Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteersMu Seong Ban, Yu Kyong Kim, Byungwook Kim, et al.
Clinical and Translational Science|August 26, 2023
Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptomsKi Young Huh, Woo Kyung Chung, Jiyeon Park, et al.
Clinical Therapeutics|September 27, 2020
Pharmacokinetics and Tolerability of LC28-0126, a Novel Necrosis Inhibitor, After Multiple Ascending Doses: A Phase I Randomized, Double-blind, Placebo-controlled Study in Healthy Male SubjectsEunwoo Kim, Inyoung Hwang, SeungHwan Lee, et al.
Drug Design, Development and Therapy|October 23, 2014
Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I studySeokuee Kim, Jongtae Lee, Donghoon Shin, et al.
Pharmaceutical Research|October 17, 2018
Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction PotentialsSu-Jin Rhee, Hyun A Lee, Soyoung Lee, et al.
Drug Design, Development and Therapy|July 31, 2023
Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean SubjectsXu Jiang, Sungyeun Bae, Deok Yong Yoon, et al.
Clinical and Translational Science|May 13, 2021
Effects of vancomycin-induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjectsEunwoo Kim, Andrew Hyoungjin Kim, Yujin Lee, et al.
Basic & Clinical Pharmacology & Toxicology|August 24, 2017
Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing NomogramSeonghae Yoon, Kyoung Ryun Park, SeungHwan Lee, et al.
Pageof 35

Showing results (111-120 of 349) with videos related to

Sort By:
Pageof 35
Clinical and Translational Science|October 20, 2021
Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non-JapaneseEunsol Yang, Jung Sunwoo, Ki Young Huh, et al.
Clinical Pharmacology in Drug Development|June 23, 2021
Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan and Chlorthalidone Compared to Concurrent Administration of the Separate ComponentsInseung Jeon, Seol Ju Moon, Sang-In Park, et al.
Translational and Clinical Pharmacology|January 11, 2021
Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteersMu Seong Ban, Yu Kyong Kim, Byungwook Kim, et al.
Clinical and Translational Science|August 26, 2023
Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptomsKi Young Huh, Woo Kyung Chung, Jiyeon Park, et al.
Clinical Therapeutics|September 27, 2020
Pharmacokinetics and Tolerability of LC28-0126, a Novel Necrosis Inhibitor, After Multiple Ascending Doses: A Phase I Randomized, Double-blind, Placebo-controlled Study in Healthy Male SubjectsEunwoo Kim, Inyoung Hwang, SeungHwan Lee, et al.
Drug Design, Development and Therapy|October 23, 2014
Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I studySeokuee Kim, Jongtae Lee, Donghoon Shin, et al.
Pharmaceutical Research|October 17, 2018
Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction PotentialsSu-Jin Rhee, Hyun A Lee, Soyoung Lee, et al.
Drug Design, Development and Therapy|July 31, 2023
Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean SubjectsXu Jiang, Sungyeun Bae, Deok Yong Yoon, et al.
Clinical and Translational Science|May 13, 2021
Effects of vancomycin-induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjectsEunwoo Kim, Andrew Hyoungjin Kim, Yujin Lee, et al.
Basic & Clinical Pharmacology & Toxicology|August 24, 2017
Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing NomogramSeonghae Yoon, Kyoung Ryun Park, SeungHwan Lee, et al.
Pageof 35